Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 EX-1.1
- 3.1 EX-3.1
- 3.2 EX-3.2
- 3.3 EX-3.3
- 3.4 EX-3.4
- 4.1 EX-4.1
- 4.2 EX-4.2
- 4.3 EX-4.3
- 4.4 EX-4.4
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 23.1 EX-23.1
Associated filings
- 16 Dec 20 424B4 Prospectus supplement with pricing info
- 16 Dec 20 EFFECT Notice of effectiveness
- 9 Dec 20 S-1/A IPO registration (amended)
-
8 Dec 20 S-1/A IPO registration (amended)
- 13 Nov 20 S-1 IPO registration
BCAB similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated October 5, 2020 (except for the last paragraph of Note 12, as to which the date is December 8, 2020) in Amendment No. 1 to the Registration Statement on Form S-1 (No. 333-250093) and the related Prospectus of BioAtla, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
San Diego, California
December 8, 2020